Appointment follows commencement of Phase 2 RESOLVE-1 trial of oral NLRP3 inflammasome inhibitor NT-0796 in patients with ...

AstraZeneca has revealed the ... but also the built environment of Cambridge and the environment, resulting in a low rise building with many eco-features, such as "green roofs" across the site.

How are contractors meeting the challenges of designing life sciences buildings that are fit for the future? In south London, ...

AZ has asked Cambridge City Council’s planning committee to allow builders to stay late to get work done as fast as possible. AstraZeneca said that the with the scaled-up building work ...

Sotheby’s has finally revealed what its plans are for Breuer’s building. Today, the international auction house, alongside the Pritzker prize-winning architecture firm Herzog & de Meuron, unveiled ...

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...

AstraZeneca announced a strategic research collaboration with CSPC Pharmaceuticals to advance AI-enabled drug discovery. This partnership aims to develop novel o ...

AstraZeneca could spend up to $5.3 billion in a deal to develop oral medicines with CSPC Pharmaceutical. Elsewhere, Insmed ...

67 Bricks CEO, Jennifer Schivas, has been named as one of EQL:Her‘s 2025 InspiringFifty.

Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as ...